SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 28th Annual J.P.